stephen silberstein, md, director, jefferson university headache center.
.
?????
.
.
.
share on google plus google-plus
.treatment delays are also causing needless anxiety and distress to patients as well as putting lives at serious risk (file pic)
.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018.
.
subscribe today to be the first to to know about breaking news and special reports.